APA

Matasi J. J., Caldwell J. P., Zhang H., Fawzi A., Higgins G. A., Cohen-Williams M. E., Varty G. B. & Tulshian D. B. (20051205). 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2. : Bioorganic & medicinal chemistry letters.

Chicago

Matasi Julius J, Caldwell John P, Zhang Hongtao, Fawzi Ahmad, Higgins Guy A, Cohen-Williams Mary E, Varty Geoffrey B and Tulshian Deen B. 20051205. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2. : Bioorganic & medicinal chemistry letters.

Harvard

Matasi J. J., Caldwell J. P., Zhang H., Fawzi A., Higgins G. A., Cohen-Williams M. E., Varty G. B. and Tulshian D. B. (20051205). 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2. : Bioorganic & medicinal chemistry letters.

MLA

Matasi Julius J, Caldwell John P, Zhang Hongtao, Fawzi Ahmad, Higgins Guy A, Cohen-Williams Mary E, Varty Geoffrey B and Tulshian Deen B. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs as adenosine A2A antagonists: the successful reduction of hERG activity. Part 2. : Bioorganic & medicinal chemistry letters. 20051205.